Bryan Johnson's ongoing relationship with Blueprint co-founder Kate Tolo remains the core driver of trader sentiment on time-bound markets about his sexual activity. Public X posts detail scheduled intimacy tracked via biomarkers like prolactin and oxytocin, plus microbiome testing framed as part of his longevity protocol that treats sexual function as a measurable health metric alongside wearables and recovery scores. Separate beds optimize sleep data, while rigid daily routines and recent autoimmune gastritis diagnosis introduce scheduling constraints that traders weigh against his history of transparent disclosures. Upcoming catalysts include any new protocol updates or relationship milestones that could shift implied probabilities based on verifiable announcements rather than speculation.